A Southwest Oncology Group Randomized Phase II Study of doxorubicin and paclitaxel as frontline chemotherapy for women with metastatic breast cancer.

Publication Type:

Journal Article


Breast cancer research and treatment, Volume 85, Issue 2, p.143-50 (2004)


Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Breast Neoplasms, Cyclophosphamide, Doxorubicin, Female, Humans, Infusions, Intravenous, Middle Aged, Neoplasm Metastasis, Treatment Outcome


To evaluate whether the high complete response (CR) rates for the combination of doxorubicin and paclitaxel in metastatic breast cancer observed in two European studies could be replicated in a multi-institutional cooperative group trial.